Evidence map›Paper›PMID 36978418›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections.

Anna Ramata-Stunda, Martins Boroduskis, Elza Kaktina, Liene Patetko, Uldis Kalnenieks, Zane Lasa, Marta Rubina, Inese Strazdina, Gints Kalnins, Reinis Rutkis

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Eminent Antimicrobial Peptide Resistance inAntibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anna Ramata-StundaAlternative Plants Ltd., 2 Podraga Str., LV-1007 Riga, Latvia.ORCID 0000-0003-0097-0931
Martins BoroduskisAlternative Plants Ltd., 2 Podraga Str., LV-1007 Riga, Latvia.
Elza KaktinaAlternative Plants Ltd., 2 Podraga Str., LV-1007 Riga, Latvia.
Liene PatetkoLaboratory of Bioanalytical and Biodosimetry Methods, Faculty of Biology, University of Latvia, 3 Jelgavas Str., LV-1004 Riga, Latvia.
Uldis KalnenieksAlternative Plants Ltd., 2 Podraga Str., LV-1007 Riga, Latvia.
Zane LasaInstitute of Microbiology and Biotechnology, University of Latvia, 1 Jelgavas Str., LV-1004 Riga, Latvia.
Marta RubinaInstitute of Microbiology and Biotechnology, University of Latvia, 1 Jelgavas Str., LV-1004 Riga, Latvia.
Inese StrazdinaInstitute of Microbiology and Biotechnology, University of Latvia, 1 Jelgavas Str., LV-1004 Riga, Latvia.
Gints KalninsLatvian Biomedical Research and Study Centre, 1 Ratsupites Str., LV-1067 Riga, Latvia.
Reinis RutkisInstitute of Microbiology and Biotechnology, University of Latvia, 1 Jelgavas Str., LV-1004 Riga, Latvia.
University of Latvia · LVLatvian Biomedical Research and Study Centre · LV

Funding

European Reconstruction and Development Fund 1.1.1.1/19/A/097
6 · The paper itself

Abstract

Skin and soft tissue infections (SSTIs) and acne are among the most common skin conditions in primary care. SSTIs caused by ESKAPE pathogens (

Indexed as

acneantimicrobial peptidescytotoxicityskin pathogens

Identifiers

PMID36978418
PMCPMC10044245
OpenAlexW4323842336

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read109
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.